AKT1 and medulloblastoma: In a previous study, Yang et al. demonstrated that sunitinib enhanced the apoptosis of medulloblastoma through the inhibition of the signal transducer and activator of transcription and PI3K-protein kinase B (AKT) signaling pathway [132,133].